(a)There is a Surveillance and Evaluation Component in the Program.
(b)The purpose of the Surveillance and Evaluation Component is to:
(1)Collect, analyze, and monitor data relating to:
(ii)As determined by the Department, nontargeted cancers; and
(iii)Cancer prevention, education, screening, and treatment programs in the State;
(2)Measure and evaluate the results of the Program, including the results of each component of the Program;
(3)Conduct the Baseline Cancer Study, as provided under subsections (c) and (d) of this section; and
(4)Conduct a Biennial Cancer Study, as provided under § 13-1104 of this subtitle.
(c)(1) To initiate the Survei
Free access — add to your briefcase to read the full text and ask questions with AI
(a) There is a Surveillance and Evaluation Component in the Program.
(b) The purpose of the Surveillance and Evaluation Component is to:
(1) Collect, analyze, and monitor data relating to:
(i) Targeted cancers;
(ii) As determined by the Department, nontargeted cancers; and
(iii) Cancer prevention, education, screening, and treatment programs in the State;
(2) Measure and evaluate the results of the Program, including the results of each component of the Program;
(3) Conduct the Baseline Cancer Study, as provided under subsections (c) and (d) of this section; and
(4) Conduct a Biennial Cancer Study, as provided under § 13-1104 of this subtitle.
(c) (1) To initiate the Surveillance and Evaluation Component, the Department shall conduct a comprehensive statewide Baseline Cancer Study as provided in this section.
(2) The Department may:
(i) Conduct the Baseline Cancer Study or any part of the Study; or
(ii) Contract with a higher education institution or private entity to conduct the Baseline Cancer Study or any part of the Study.
(d) The Baseline Cancer Study shall measure:
(1) The number and percentage of individuals who have each targeted cancer, both statewide and in each county;
(2) The number and percentage of individuals within each minority population who have each targeted cancer, both statewide and in each county;
(3) The mortality rate for each targeted cancer, both statewide and in each county;
(4) The mortality rate for different minority populations for each targeted cancer, both statewide and in each county;
(5) The number of identifiable cancers with a high incidence in the State for which there are effective methods of:
(i) Early detection; and
(ii) Prevention and treatment after detection;
(6) Any aspect of targeted and nontargeted cancers that the Department seeks to measure; and
(7) Any other factor that the Department determines to be important for measuring rates of cancers in the State or for evaluating whether the Program meets its objectives.
(e) In order to maximize the cost effectiveness of the Baseline Cancer Study, the Department may use data in the Maryland Cancer Registry or provided by other sources, to the extent that these sources provide reliable data relating to the factors listed in subsection (d) of this section.
(f) (1) If the Department chooses to have a higher education institution or private entity conduct the Baseline Cancer Study or any part of the Study, the Department shall issue a request for proposal to select the entity that will conduct the Study or the relevant part of the Study.
(2) The request for proposal shall require that any methodology or model that is used by the entity to conduct the Baseline Cancer Study or the relevant part of the Study, any data collected under the Study, and any electronic files, codes, and definitions relating to the Study be provided to the State for use in subsequent studies, regardless of whether the studies are conducted by the same entity.
(3) The Department may contract with an entity to conduct the Baseline Cancer Study and one or more biennial cancer studies as required under § 13-1104 of this subtitle.